Dyspareunia Due to Vulvar and Vaginal Atrophy Resulting From Menopause
📧 Sign up to get email alerts when something new happens for Dyspareunia Due to Vulvar and Vaginal Atrophy Resulting From Menopause.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-03-17FDA Approved: OSPHENA — Supplemental Application (Duchesnay USA, Inc.)
FDA approved a supplemental application for OSPHENA (ospemifene) filed by Duchesnay USA, Inc.